BARCLAYS PLC

Position in AUTL — Autolus Therapeutics plc

CIK 312069 LONDON, X0

Position in AUTL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$19,102

+$7,961 QoQ

Shares Held

11,939

+47.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 84 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. AUTL ranks #310 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,102	11,939	+47.9%	Shares	Defined	2026-08-14
2026-03-31	$11,141	8,074	+2.4%	Shares	Defined	2026-05-15
2025-09-30	$12,849	7,883	-50.1%	Shares	Sole	2026-03-31
2025-06-30	$36,024	15,800	+4.9%	Shares	Sole	2026-02-27
2025-03-31	$23,355	15,068	+27.1%	Shares	Sole	2026-03-17
2024-12-31	$27,868	11,859	+1094.3%	Shares	Sole	2026-03-19
2024-09-30	$3,604	993	-93.4%	Shares	Sole	2026-03-31
2022-03-31	$62,858	15,074	+376750.0%	Shares	Sole	2022-05-16
2021-09-30	$26	4	-92.7%	Shares	Sole	2021-11-09
2021-06-30	$365	55	-38.9%	Shares	Sole	2021-08-13
2021-03-31	$515	90	-39.2%	Shares	Sole	2021-05-13
2020-12-31	$1,323	148	+208.3%	Shares	Sole	2021-02-11
2020-09-30	$558	48	0.0%	Shares	Sole	2020-11-12
2020-06-30	$769	48	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.